A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era

A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era

Abstract EBV‐positive diffuse large B‐cell lymphoma (DLBCL), not otherwise specified (NOS), often affects the gastrointestinal tract. However, the prognostic significance of EBV associated with primary gastric DLBCL (gDLBCL) has not been established. This retrospective study included 240 patients wi...

Full description

Bibliographic Details
Main Authors: Eri Ishikawa, Tsutomu Tanaka, Kazuyuki Shimada, Kei Kohno, Akira Satou, Ahmed E. Eladl, Ayako Sakakibara, Kazuhiro Furukawa, Kohei Funasaka, Ryoji Miyahara, Masanao Nakamura, Hidemi Goto, Shigeo Nakamura, Seiichi Kato, Yoshiki Hirooka
Format: Article
Language:English
Published: Wiley 2018-07-01
Series:Cancer Medicine
Subjects:
diffuse large B‐cell lymphoma
Epstein‐Barr virus
gastric lymphoma
PD‐L1
rituximab
Online Access:https://doi.org/10.1002/cam4.1595

Internet

https://doi.org/10.1002/cam4.1595

Similar Items